German cannabis industry disputes Berlin data on abuse cases
Industry challenges government statistics on cannabis-related abuse, amid rapid market expansion and regulatory tightening.
FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0Germany's cannabis industry is pushing back against official data from Berlin on abuse cases, according to Business of Cannabis. The challenge comes as the market continues to mature following legalization, with cultivation licenses approaching 500 and product diversity expanding rapidly—flower SKUs jumped 73% while prices fell 22% in recent months.
The dispute signals potential friction between regulators and operators over how harms are measured and attributed. Berlin has implemented several restrictions, including capping medical cannabis access at 300 tons annually and tightening insurance requirements, though the government softened some reforms under industry lobbying. The data dispute may foreshadow further regulatory negotiations as both sides assess legalization's real-world effects.
Watch whether this challenge leads to independent abuse-incidence studies or revised government methodology—a move that could either validate industry claims or expose underreporting gaps.
Original report: Business of Cannabis ↗